‘‘I believe that beginning 2014 will see a change in the landscape’’

Read more

‘’Indian regulatory scenario is far from rosy at these times’’

Read more

‘‘Let this be the tipping point, but in a way that is to the benefit of all stakeholders’’

Read more

‘’Game cards need to be played with lot of concentration and long-term vision’’

Read more

Raise your game – Expand your horizons in the Indian OTC market

Read more

Rising above Neglect

Read more

Jubilant Biosys files IND with US-based Endo Pharmaceuticals

Read more

DoP extends excise duty exemption on formulations under DPCO 2013

Read more

World’’s pharma development manufacturing base moving to India: IBEF

Read more

Ranbaxy allocates site for greenfield manufacturing facility in Malaysia

Read more